SCHIP1 (schwannomin interacting protein 1) is a multifunctional cytoplasmic protein involved in cell signaling, cytoskeletal dynamics, and developmental processes. Structurally, SCHIP1 exists as multiple isoforms, including a fusion transcript with IQCJ (IQCJ-SCHIP1), and localizes to the cytoplasm, actin-rich cellular regions, and cell junctions 1. Functionally, SCHIP1 interacts with the NF2 tumor suppressor merlin and participates in multiple signaling pathways 2. In podocytes, SCHIP1 mediates actin cytoskeleton rearrangements by forming a complex with Nherf2 and ezrin, regulating cortical F-actin dynamics in response to PDGF signaling 3. In osteoclasts, SCHIP1 promotes differentiation through Taok1-mediated p38 MAPK pathway activation, with SCHIP1 knockout mice showing resistance to osteoporosis 4. SCHIP1 is critical for craniofacial development, with genome-wide association studies identifying SCHIP1 variants associated with facial size and shape in African populations 5, and a human homozygous nonsense mutation causing neurodevelopmental disorder with brain malformations, hearing impairment, and cataracts 6. Additionally, SCHIP1 associates with late-life memory performance in a sex-specific manner 7. These diverse functions indicate SCHIP1 as a regulatory hub affecting skeletal, renal, neurological, and cognitive health.